1. |
Scholten ET, de Jong PA, de Hoop B, et al. Towards a close computed tomography monitoring approach for screen detected subsolid pulmonary nodules? Eur Respir J, 2015, 45(3): 765-773.
|
2. |
Seo JB, Im JG, Goo JM, et al. Atypical pulmonary metastases: Spectrum of radiologic findings. Radiographics, 2001, 21(2): 403-417.
|
3. |
Yu H, Liu S, Zhang C, et al. Computed tomography and pathology evaluation of lung ground-glass opacity. Exp Ther Med, 2018, 16(6): 5305-5309.
|
4. |
Woodring JH, Bognar B. CT halo sign in pulmonary metastases from mucinous adenocarcinoma of the pancreas. South Med J, 2001, 94(4): 448-449.
|
5. |
Okita R, Yamashita M, Nakata M, et al. Multiple ground-glass opacity in metastasis of malignant melanoma diagnosed by lung biopsy. Ann Thorac Surg, 2005, 79(1): e1-e2.
|
6. |
Kim SB, Lee S, Koh MJ, et al. Ground-glass opacity in lung metastasis from breast cancer: A case report. Tuberc Respir Dis (Seoul), 2013, 74(1): 32-36.
|
7. |
Nakamura S, Goto T, Nara S, et al. Pure ground glass opacity (GGO) on chest CT: A rare presentation of lung metastasis of malignant phyllodes tumor. Breast Cancer, 2020, 27(6): 1187-1190.
|
8. |
Shigefuku S, Shimada Y, Hagiwara M, et al. Prognostic significance of ground-glass opacity components in 5-year survivors with resected lung adenocarcinoma. Ann Surg Oncol, 2021, 28(1): 148-156.
|
9. |
MacMahon H, Naidich DP, Goo JM, et al. Guidelines for management of incidental pulmonary nodules detected on CT images: From the Fleischner Society 2017. Radiology, 2017, 284(1): 228-243.
|
10. |
张晓菊, 白莉, 金发光, 等. 肺结节诊治中国专家共识(2018年版). 中华结核和呼吸杂志, 2018, 41(10): 763-771.
|
11. |
Zhang Y, Fu F, Chen H. Management of ground-glass opacities in the lung cancer spectrum. Ann Thorac Surg, 2020, 110(6): 1796-1804.
|
12. |
Zhuge L, Huang Y, Wang S, et al. Preoperative brain MRI for clinical stageⅠA lung cancer: Is routine scanning rational? J Cancer Res Clin Oncol, 2019, 145(2): 503-509.
|
13. |
Veronesi G, Travaini LL, Maisonneuve P, et al. Positron emission tomography in the diagnostic work-up of screening-detected lung nodules. Eur Respir J, 2015, 45(2): 501-510.
|
14. |
Li H, Hu H, Wang R, et al. When should ⁹⁹mTc bone scintigraphy be performed in cT1N0 non-small cell lung cancer patients? Medicine (Baltimore), 2015, 94(51): e2309.
|
15. |
Murabito M, Salat A, Mueller MR. Complete resection of isolated lung metastasis from breast carcinoma results in a strong increase in survival. Minerva Chir, 2000, 55(3): 121-127.
|
16. |
Schirren J, Schirren M, Lampl L, et al. Surgery for pulmonary metastases: quo vadis? Eur J Cardiothorac Surg, 2017, 51(3): 408-410.
|
17. |
刘波, 夏晖. 肺转移瘤的外科治疗进展. 中国肺癌杂志, 2019, 22(9): 574-578.
|
18. |
Patrini D, Panagiotopoulos N, Lawrence D, et al. Surgical management of lung metastases. Br J Hosp Med (Lond), 2017, 78(4): 192-198.
|
19. |
Handy JR, Bremner RM, Crocenzi TS, et al. Expert consensus document on pulmonary metastasectomy. Ann Thorac Surg, 2019, 107(2): 631-649.
|
20. |
Saji H, Okada M, Tsuboi M, et al. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): A multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial. Lancet, 2022, 399(10335): 1607-1617.
|
21. |
Mangiameli G, Cioffi U, Alloisio M, et al. Pulmonary metastases: Surgical principles, surgical indications, and innovations. Sergi CM. Metastasis. Brisbane (AU): Exon Publications. 2022.
|